These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2582553)

  • 101. DNA content of human squamous cell carcinoma cell lines. Analysis by flow cytometry and chromosome enumeration.
    Roa RA; Carey TE; Passamani PP; Greenwood JH; Hsu S; Ridings EO; Schwartz DR; Wolf GT; Hudson JL
    Arch Otolaryngol; 1985 Sep; 111(9):565-75. PubMed ID: 2411248
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A misleading flow cytometric analysis of DNA in an adenocarcinoma: a comparative flow cytometric and cytogenetic study.
    Lee GM; Youngberg GA
    J Surg Oncol; 1986 Apr; 31(4):275-8. PubMed ID: 3724183
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma.
    Otto U; Baisch H; Huland H; Klöppel G
    J Urol; 1984 Aug; 132(2):237-9. PubMed ID: 6737570
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Research on the squamous cell carcinoma of the cervix uteri by cytophotometric and planimetric evaluations (author's transl)].
    Herzog RE
    Beitr Pathol; 1977 Sep; 161(1):62-71. PubMed ID: 921705
    [No Abstract]   [Full Text] [Related]  

  • 105. DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma.
    Asamura H; Nakajima T; Mukai K; Noguchi M; Shimosato Y
    Cancer; 1989 Oct; 64(8):1657-64. PubMed ID: 2790679
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Histographic DNA pattern as an aid for diagnosis and therapy of minimal invasive endometrial cancer.
    Herzog RE; Pellicer A
    Onkologie; 1984 Feb; 7(1):27-31. PubMed ID: 6369204
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [Assessment of prognostic criteria in uterine carcinomas (author's transl)].
    Baltzer J
    Geburtshilfe Frauenheilkd; 1981 Oct; 41(10):663-7. PubMed ID: 6274736
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Flow cytometry DNA analysis on tumor cell subpopulation of human tumor specimens by exclusion of lymphohemopoietic cells.
    Park CH; Lee SH; Stephens RL; Smith TK; Park MH
    J Histochem Cytochem; 1988 Jun; 36(6):705-9. PubMed ID: 3367054
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Malignant melanoma: analysis by DNA flow cytometry.
    Wass J; Zbroja RA; Young GA; Vincent PC; Joyce RM; Croaker G
    Pathology; 1985 Jul; 17(3):475-80. PubMed ID: 4069767
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Fundamental studies of a squamous cell carcinoma radioimmunoassay kit].
    Kanamori I; Nakano S; Yanase M; Yoshida H; Yabashi T; Higuchi C; Iwata F; Kawase A; Hattori Y; Yamada Y
    Radioisotopes; 1985 Nov; 34(11):636-9. PubMed ID: 3834526
    [No Abstract]   [Full Text] [Related]  

  • 111. The prognostic significance of growth pattern and its relation to tumor cell nuclear DNA content in endometrial carcinoma.
    Moberger B; Auer G; Einhorn N; Moberger G
    Acta Oncol; 1990; 29(1):17-23. PubMed ID: 2310599
    [TBL] [Abstract][Full Text] [Related]  

  • 112. THE CHROMOSOMAL CHANGES IN MALIGNANCY; AN ASSESSMENT OF THEIR POSSIBLE PROGNOSTIC SIGNIFICANCE.
    ATKIN NB
    Br J Radiol; 1964 Mar; 37():213-8. PubMed ID: 14132046
    [No Abstract]   [Full Text] [Related]  

  • 113. Peculiarities of cytochemical properties of cancer cells as revealed by study of deoxyribonucleoprotein susceptibility to Feulgen hydrolysis.
    Zelenin AV; Kushch AA; Chebanu TA
    J Histochem Cytochem; 1977 Jul; 25(7):580-4. PubMed ID: 70449
    [TBL] [Abstract][Full Text] [Related]  

  • 114. DNA distribution in biopsy specimens from human cervical carcinoma investigated by flow cytometry.
    Jakobsen A; Bichel P; Sell A
    Virchows Arch B Cell Pathol; 1979 Feb; 29(4):337-42. PubMed ID: 105469
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The close follow-up of immunosuppressed renal recipient women through colposcopy, cervical biopsy and FCM DNA content analysis.
    Sert MB; Kaern J; Trope C
    Eur J Cancer; 1991; 27(3):302. PubMed ID: 1827319
    [No Abstract]   [Full Text] [Related]  

  • 116. The use of microspectrophotometry.
    Atkin NB
    Obstet Gynecol Surv; 1969 Jul; 24(7 Pt 2):794-804. PubMed ID: 5212430
    [No Abstract]   [Full Text] [Related]  

  • 117. Immunohistochemical assessment of the growth fraction in cervical cancers using the monoclonal antibody Ki-67; relationship to the clinical stage, histologic type and DNA content.
    Masuda T; Yabushita H; Sawaguchi K; Noguchi M; Nakanishi M
    Asia Oceania J Obstet Gynaecol; 1992 Mar; 18(1):81-7. PubMed ID: 1627063
    [TBL] [Abstract][Full Text] [Related]  

  • 118. DNA in human tumors: a cytophotometric study.
    Böhm N; Sandritter W
    Curr Top Pathol; 1975; 60():151-219. PubMed ID: 1104277
    [No Abstract]   [Full Text] [Related]  

  • 119. Feulgen microdensitometry and analysis of S-phase cells in cervical tumour biopsies.
    Dixon B; Stead RH
    J Clin Pathol; 1977 Oct; 30(10):907-13. PubMed ID: 563415
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Nuclear DNA content in endolymphatic stromal myosis.
    Goldfarb S; Richart RM; Okagaki T
    Am J Obstet Gynecol; 1970 Feb; 106(4):524-9. PubMed ID: 5412844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.